Hefei Lifeon Pharmaceutical Co Ltd (003020) — Strategic Asset Allocation Index
Hefei Lifeon Pharmaceutical Co Ltd (003020) has a Strategic Asset Allocation Index of 42.3% as of September 2023. Strategic assets (PP&E of CN¥740.45 Million plus long-term investments of CN¥-) total CN¥740.45 Million, measured against net assets of CN¥1.75 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Hefei Lifeon Pharmaceutical Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Hefei Lifeon Pharmaceutical Co Ltd Strategic Asset Allocation Index (2019–2020)
This chart shows how Hefei Lifeon Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 2 annual periods from 2019 to 2020. As of September 2023, the index stands at 42.3%, representing strategic assets of CN¥740.45 Million against net assets of CN¥1.75 Billion CNY. See 003020 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Hefei Lifeon Pharmaceutical Co Ltd (2019–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Hefei Lifeon Pharmaceutical Co Ltd from 2019 to 2020, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Hefei Lifeon Pharmaceutical Co Ltd (003020) market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 17.0% | CN¥199.03 Million | CN¥199.03 Million | CN¥- | CN¥1.17 Billion | ▼ -7.8 pp |
| 2019 | 24.8% | CN¥146.10 Million | CN¥146.10 Million | CN¥- | CN¥590.00 Million | — |